Related Experiment Video

Updated: Jan 18, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K

Early Immunosuppression as CRS Prophylaxis in Outpatient Haploidentical Transplants: A Randomized Phase II Study

Perla R Colunga-Pedraza1, Héctor A Vaquera-Alfaro1, Andrés Gómez-De León1

  • 1Servicio de Hematología, Hospital Universitario "Dr. José Eleuterio González", Universidad Autónoma de Nuevo León, Monterrey, Nuevo León, México.

Transplantation and Cellular Therapy
|September 10, 2025
PubMed
Abstract

No abstract available in PubMed .

Keywords:
Cytokine release syndromeHematopoietic stem cell transplant

More Related Videos

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.9K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.9K

Related Experiment Videos

Last Updated: Jan 18, 2026

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation
11:49

Trans-vivo Delayed Type Hypersensitivity Assay for Antigen Specific Regulation

Published on: May 2, 2013

16.6K
Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade
11:55

Induction of Alloantigen-specific Anergy in Human Peripheral Blood Mononuclear Cells by Alloantigen Stimulation with Co-stimulatory Signal Blockade

Published on: March 14, 2011

14.9K
In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients
18:48

In Vitro and In Vivo Assessment of T, B and Myeloid Cells Suppressive Activity and Humoral Responses from Transplant Recipients

Published on: August 12, 2017

14.9K

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

83.5K
Overview
83.5K
Kidney Transplant II: Surgical Procedure01:26

Kidney Transplant II: Surgical Procedure

325
Preoperative ManagementThe primary goals of preoperative management in kidney transplantation are to optimize the patient’s metabolic state and prepare them for surgery through diet adjustments, necessary dialysis, and tailored medical treatment. This phase also involves comprehensive infection screening and patient education about the surgical procedure and postoperative care to improve outcomes and adherence.Medical ManagementA comprehensive evaluation is required for both the living...
325

Articles linked to this work by shared authors, journal, and citation graph.

Improving engraftment in autologous hematopoietic stem cell transplantation: comparing pegfilgrastim with filgrastim in an outpatient setting.

Hematology, transfusion and cell therapy·2026

Mast Cells Control the Bacterial Burden and Grain Formation in Murine Experimental Actinomycetoma Induced by Nocardia brasiliensis.

Pathogens & immunity·2026

Mapping the capacity for geriatric blood Cancer Care in Latin America: A cross- sectional survey of current status and future priorities.

Journal of geriatric oncology·2026

Temporal variability in outcomes of identical regimens across newly diagnosed myeloma trials: a systematic review.

EClinicalMedicine·2026

Current landscape of academic and point of care CAR-T cell therapy in low-middle income countries.

Clinical hematology international·2026

Association of MRD Status With Survival Outcomes and Cytokine Release Syndrome in Outpatient Transplantation After Reduced-Intensity Conditioning for Acute Lymphoblastic Leukemia: Experience From a Low- and Middle-Income Country Reference Center.

Transplantation and cellular therapy·2026

Acalabrutinib for treatment of steroid-refractory chronic graft vs. host disease.

Transplantation and cellular therapy·2026

A novel conditioning regimen incorporating low-dose cyclophosphamide and thiotepa for haploidentical hematopoietic stem cell transplantation in pediatric patients with severe aplastic anemia at high risk of cardiotoxicity.

Transplantation and cellular therapy·2026

Venetoclax-augmented RIC allogeneic HCT with PTCy-based GVHD prophylaxis and venetoclax/azacitidine maintenance for poor risk MDS and AML.

Transplantation and cellular therapy·2026

High Predicted Thiotepa Exposure is Associated with Increased Risk of Thrombotic Microangiopathy and Non-Relapse Mortality in Pediatric Patients Undergoing Alpha-Beta T-Cell Depleted Haploidentical Transplantation.

Transplantation and cellular therapy·2026

Breast cancer risk among survivors of hematopoietic stem cell transplant with or without total body irradiation: A population-based analysis.

Transplantation and cellular therapy·2026

Feasibility of 8 Gy TBI-Busulfan-Fludarabine Conditioning with Post-Transplant Cyclophosphamide for Pediatric High-Risk or Relapsed Acute Lymphoblastic Leukemia.

Transplantation and cellular therapy·2026

Torque Teno Virus (TTV) Viremia as a Biomarker of Immune Reconstitution and Outcomes in Pediatric Allogeneic Hematopoietic Stem Cell Transplantation.

Journal of medical virology·2026

Retrospective cohort study of epitope-based virtual crossmatch allocation in a public transplant system (Pernambuco, Brazil).

Frontiers in immunology·2026

First Moroccan ABO-Incompatible Living Donor Kidney Transplantation: Successful Desensitization Without Intravenous Immunoglobulin.

Transplantation proceedings·2026

Human Milk Oligosaccharide (2'-FL) Modifies the Gut Microbiome in Children after Bone Marrow Transplant.

Blood·2026

Autologous immune system reset for kidney allograft acceptance: mechanisms, evidence, and a testable reconstitution-window model.

Frontiers in medicine·2026

Risk-Stratified 2 mg/kg ATG Induction in Kidney Transplantation: Comparing Two- and Three-Dose Regimens at a Single Center.

Transplantation proceedings·2026
See all related articles
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies
Jove
Visualize
Contact Us